Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease

Neurobiology of Aging

Volumn 21, Issue 1, 2000, Pages 27-30

  Merched, A ^a,c   Xia, Y ^a   Visvikis, S ^a   Serot, J M ^b   Siest, G ^a  

^a Centre de Medecine Preventive   (France)

^b HÔTEL DIEU   (France)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein A I; Biochemical marker; Mini mental score

Indexed keywords

APOLIPOPROTEIN A1; BIOCHEMICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; CHOLESTEROL, HDL; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 0034594467     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(99)00103-7     Document Type: Article

References (20)

1. Borghini I., Barja F., Pometta D., James R.W. Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim Biophys Acta. 1255:1995;192-200.
2. Boyles J.K., Zoellner C.D., Anderson L.J., Kosik L.M., Pitas R.E., Weisgraber K.H., Hui D.Y., Mahley R.W., Gebicke-Haerter P.J., Ignatius M.J., et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest. 83:1989;1015-1031.
3. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:1975;189-198.
4. Golabek A., Marques M.A., Lalowski M., Wisniewski T. Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid. Neurosci Lett. 191:1995;79-82.
5. Harr S.D., Uint L., Hollister R., Hyman B.T., Mendez A.J. Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J Neurochem. 66:1996;2429-2435.
6. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 31:1990;545-548.
7. Kawano M., Kawakami M., Otsuka M., Yashima H., Yaginuma T., Ueki A. Marked decrease of plasma apolipoprotein AI and AII in Japanese patients with late-onset non-familial Alzheimer's disease [letter]. Clin Chim Acta. 239:1995;209-211.
8. Koudinov A., Matsubara E., Frangione B., Ghiso J. The soluble form of Alzheimer's amyloid beta protein is complexed to high density li-poprotein 3 and very high density lipoprotein in normal human plasma. Biochem Biophys Res Commun. 205:1994;1164-1171.
9. Kuriyama M., Takahashi K., Yamano T., Hokezu Y., Togo S., Osame M., Igakura T. Low levels of serum apolipoprotein A I and A II in senile dementia. Jpn J Psychiatry Neurol. 48:1994;589-593.
10. Luoma P.V. Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevity. Pharmacol Toxicol. 81:1997;57-64.
11. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
12. Pitas R.E., Boyles J.K., Lee S.H., Hui D., Weisgraber K.H. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem. 262:1987;14352-14360.
13. Rosenson R.S. Beyond low-density lipoprotein cholesterol. A perspective on low high- density lipoprotein disorders and Lp(a) lipoprotein excess. Arch Intern Med. 156:1996;1278-1284.
14. Saito K., Seishima M., Heyes M.P., Song H., Fujigaki S., Maeda S., Vickers J.H., Noma A. Marked increases in concentrations of apolipoprotein in the cerebrospinal fluid of poliovirus-infected macaques relations between apolipoprotein concentrations and severity of brain injury . Biochem J. 321:1997;145-149.
15. Song H., Saito K., Seishima M., Noma A., Urakami K., Nakashima K. Cerebrospinal fluid apo E and apo A-I concentrations in early- and late- onset Alzheimer's disease. Neurosci Lett. 231:1997;175-178.
16. Stuart W.D., Krol B., Jenkins S.H., Harmony J.A. Structure and stability of apolipoprotein J-containing high-density lipoproteins. Biochemistry. 31:1992;8552-8559.
17. Tape C., Kisilevsky R. Apolipoprotein A-I and apolipoprotein SAA half-lives during acute inflammation and amyloidogenesis. Biochim Biophys Acta. 1043:1990;295-300.
18. Wisniewski T., Golabek A.A., Kida E., Wisniewski K.E., Frangione B. Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis. Am J Pathol. 147:1995;238-244.
19. Zlokovic B.V., Martel C.L., Mackic J.B., Matsubara E., Wisniewski T., McComb J.G., Frangione B., Ghiso J. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta. Biochem Biophys Res Commun. 205:1994;1431-1437.
20. Zlokovic B.V., Martel C.L., Matsubara E., McComb J.G., Zheng G., McCluskey R.T., Frangione B., Ghiso J. Glycoprotein 330/megalin probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers . Proc Natl Acad Sci USA. 93:1996;4229-4234.